Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Lipids as the key to understanding α-synuclein behaviour in Parkinson disease

Parkinson disease is a devastating neurodegenerative condition that is characterized by intraneuronal toxic assemblies of the α-synuclein protein. In this Comment, we discuss the emerging role of lipids in understanding biology as well as in the identification of new therapeutic targets in this disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Shahmoradian, S. H. et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099–1109 (2019).

    Article  CAS  Google Scholar 

  2. Theillet, F. X. et al. Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 530, 45–50 (2016).

    Article  CAS  Google Scholar 

  3. Fusco, G. et al. Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat. Commun. 5, 3827 (2014).

    Article  CAS  Google Scholar 

  4. Galvagnion, C. et al. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein. Proc. Natl Acad. Sci. USA 113, 7065–7070 (2016).

    Article  CAS  Google Scholar 

  5. Fusco, G. et al. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers. Science 358, 1440–1443 (2017).

    Article  CAS  Google Scholar 

  6. Zunke, F. et al. Reversible conformational conversion of α-synuclein into toxic assemblies by glucosylceramide. Neuron 97, 92–107 (2018).

    Article  CAS  Google Scholar 

  7. Mazzulli, J. R. et al. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37–52 (2011).

    Article  CAS  Google Scholar 

  8. Henderson, M. X. et al. Glucocerebrosidase activity modulates neuronal susceptibility to pathological α-synuclein insult. Neuron 105, 822–836 (2019).

    Article  Google Scholar 

  9. Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).

    Article  CAS  Google Scholar 

  10. Fanning, S. et al. Lipidomic analysis of α-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol. Cell 73, 1001–1014 (2019).

    Article  CAS  Google Scholar 

Download references


We are grateful to the Azrieli Foundation for the award of an Azrieli Fellowship and Marguerite Stolz Research Fellowship.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Avraham Ashkenazi.

Ethics declarations

Competing interests

The authors declare no competing interests

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stok, R., Ashkenazi, A. Lipids as the key to understanding α-synuclein behaviour in Parkinson disease. Nat Rev Mol Cell Biol 21, 357–358 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing